Akari Therapeutics PLC (AKTX)

2.40 -0.03 (-1.21%) USD  |  NASDAQ  |  Nov 05, 09:31
More

Akari Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2022. Upgrade now.
Date Value
December 05, 2022 --
Date Value
September 30, 2022 --

Revenue Estimates for Current Quarter Range, Past 5 Years

--
Minimum
Sep 30 2022
--
Maximum
Sep 30 2022
--
Average
--
Median
Sep 30 2022

Revenue Estimates for Current Quarter Benchmarks

DBV Technologies SA Upgrade
Cellectis SA Upgrade
Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals PLC --
NuCana PLC Upgrade

Revenue Estimates for Current Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade